Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice

Hyun Ju Kim, Xian Hua Zhang, Eun Young Park, Kyung-Ho Shin, Sang-Hyun Choi, Boe Gwun Chun, Dong-Hun Kim

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Metformin is widely used to treat obese diabetics because of its beneficial effects on body weight, energy intake, and glucose regulation. However, it has not been investigated how oral metformin affects meal patterns, or whether the reduced food intake is associated with neuronal activation in the hindbrain. Accordingly, we investigated how orally administered metformin (150 or 300. mg/kg daily for 4 or 7. days) reduces body weight in obese mice on a high-fat diet by continuously measuring meal patterns, energy expenditure, and locomotor activity, and whether oral metformin (300. mg/kg daily for 3. days) increases c-Fos expression in the nucleus tractus solitarius (NTS) and area postrema. Furthermore, we determined whether oral metformin produces a conditioned taste aversion (CTA) in obese mice administered a single dose of metformin (75, 150, or 300. mg/kg, p.o.). Metformin (300. mg/kg daily for 7. days) reduced body weight and adiposity by decreasing nocturnal energy intake but did not significantly change energy expenditure or locomotor activity relative to vehicle, and it transiently decreased nocturnal meal size and reduced meal number throughout the experiments. Furthermore, metformin significantly increased c-Fos immunoreactivity within the NTS of obese mice compared to that in controls and pair-fed group, and induced a CTA at doses of 150 or 300. mg/kg. These results indicate that metformin-induced weight loss is associated with a sustained reduction in energy intake maintained by a reduction in meal size and number, and that oral administration of metformin causes visceral illness and neuronal activation in the NTS.

Original languageEnglish
Pages (from-to)213-220
Number of pages8
JournalPhysiology and Behavior
Volume110-111
DOIs
Publication statusPublished - 2013 Feb 7

Fingerprint

Obese Mice
Solitary Nucleus
Metformin
Meals
Energy Intake
Body Weight
Locomotion
Energy Metabolism
Nucleus
Mouse
Energy
Meal
Area Postrema
Rhombencephalon
Intake
Adiposity
High Fat Diet
Oral Administration
Weight Loss
Eating

Keywords

  • Conditioned taste aversion
  • Diet-induced obesity
  • Energy balance
  • Meal pattern
  • Metformin
  • Neuronal activation

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Experimental and Cognitive Psychology
  • Philosophy

Cite this

Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice. / Kim, Hyun Ju; Zhang, Xian Hua; Park, Eun Young; Shin, Kyung-Ho; Choi, Sang-Hyun; Chun, Boe Gwun; Kim, Dong-Hun.

In: Physiology and Behavior, Vol. 110-111, 07.02.2013, p. 213-220.

Research output: Contribution to journalArticle

@article{7ef9beb52c9347cfa1270e7cc3cd1ad6,
title = "Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice",
abstract = "Metformin is widely used to treat obese diabetics because of its beneficial effects on body weight, energy intake, and glucose regulation. However, it has not been investigated how oral metformin affects meal patterns, or whether the reduced food intake is associated with neuronal activation in the hindbrain. Accordingly, we investigated how orally administered metformin (150 or 300. mg/kg daily for 4 or 7. days) reduces body weight in obese mice on a high-fat diet by continuously measuring meal patterns, energy expenditure, and locomotor activity, and whether oral metformin (300. mg/kg daily for 3. days) increases c-Fos expression in the nucleus tractus solitarius (NTS) and area postrema. Furthermore, we determined whether oral metformin produces a conditioned taste aversion (CTA) in obese mice administered a single dose of metformin (75, 150, or 300. mg/kg, p.o.). Metformin (300. mg/kg daily for 7. days) reduced body weight and adiposity by decreasing nocturnal energy intake but did not significantly change energy expenditure or locomotor activity relative to vehicle, and it transiently decreased nocturnal meal size and reduced meal number throughout the experiments. Furthermore, metformin significantly increased c-Fos immunoreactivity within the NTS of obese mice compared to that in controls and pair-fed group, and induced a CTA at doses of 150 or 300. mg/kg. These results indicate that metformin-induced weight loss is associated with a sustained reduction in energy intake maintained by a reduction in meal size and number, and that oral administration of metformin causes visceral illness and neuronal activation in the NTS.",
keywords = "Conditioned taste aversion, Diet-induced obesity, Energy balance, Meal pattern, Metformin, Neuronal activation",
author = "Kim, {Hyun Ju} and Zhang, {Xian Hua} and Park, {Eun Young} and Kyung-Ho Shin and Sang-Hyun Choi and Chun, {Boe Gwun} and Dong-Hun Kim",
year = "2013",
month = "2",
day = "7",
doi = "10.1016/j.physbeh.2013.01.011",
language = "English",
volume = "110-111",
pages = "213--220",
journal = "Physiology and Behavior",
issn = "0031-9384",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice

AU - Kim, Hyun Ju

AU - Zhang, Xian Hua

AU - Park, Eun Young

AU - Shin, Kyung-Ho

AU - Choi, Sang-Hyun

AU - Chun, Boe Gwun

AU - Kim, Dong-Hun

PY - 2013/2/7

Y1 - 2013/2/7

N2 - Metformin is widely used to treat obese diabetics because of its beneficial effects on body weight, energy intake, and glucose regulation. However, it has not been investigated how oral metformin affects meal patterns, or whether the reduced food intake is associated with neuronal activation in the hindbrain. Accordingly, we investigated how orally administered metformin (150 or 300. mg/kg daily for 4 or 7. days) reduces body weight in obese mice on a high-fat diet by continuously measuring meal patterns, energy expenditure, and locomotor activity, and whether oral metformin (300. mg/kg daily for 3. days) increases c-Fos expression in the nucleus tractus solitarius (NTS) and area postrema. Furthermore, we determined whether oral metformin produces a conditioned taste aversion (CTA) in obese mice administered a single dose of metformin (75, 150, or 300. mg/kg, p.o.). Metformin (300. mg/kg daily for 7. days) reduced body weight and adiposity by decreasing nocturnal energy intake but did not significantly change energy expenditure or locomotor activity relative to vehicle, and it transiently decreased nocturnal meal size and reduced meal number throughout the experiments. Furthermore, metformin significantly increased c-Fos immunoreactivity within the NTS of obese mice compared to that in controls and pair-fed group, and induced a CTA at doses of 150 or 300. mg/kg. These results indicate that metformin-induced weight loss is associated with a sustained reduction in energy intake maintained by a reduction in meal size and number, and that oral administration of metformin causes visceral illness and neuronal activation in the NTS.

AB - Metformin is widely used to treat obese diabetics because of its beneficial effects on body weight, energy intake, and glucose regulation. However, it has not been investigated how oral metformin affects meal patterns, or whether the reduced food intake is associated with neuronal activation in the hindbrain. Accordingly, we investigated how orally administered metformin (150 or 300. mg/kg daily for 4 or 7. days) reduces body weight in obese mice on a high-fat diet by continuously measuring meal patterns, energy expenditure, and locomotor activity, and whether oral metformin (300. mg/kg daily for 3. days) increases c-Fos expression in the nucleus tractus solitarius (NTS) and area postrema. Furthermore, we determined whether oral metformin produces a conditioned taste aversion (CTA) in obese mice administered a single dose of metformin (75, 150, or 300. mg/kg, p.o.). Metformin (300. mg/kg daily for 7. days) reduced body weight and adiposity by decreasing nocturnal energy intake but did not significantly change energy expenditure or locomotor activity relative to vehicle, and it transiently decreased nocturnal meal size and reduced meal number throughout the experiments. Furthermore, metformin significantly increased c-Fos immunoreactivity within the NTS of obese mice compared to that in controls and pair-fed group, and induced a CTA at doses of 150 or 300. mg/kg. These results indicate that metformin-induced weight loss is associated with a sustained reduction in energy intake maintained by a reduction in meal size and number, and that oral administration of metformin causes visceral illness and neuronal activation in the NTS.

KW - Conditioned taste aversion

KW - Diet-induced obesity

KW - Energy balance

KW - Meal pattern

KW - Metformin

KW - Neuronal activation

UR - http://www.scopus.com/inward/record.url?scp=84875067291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875067291&partnerID=8YFLogxK

U2 - 10.1016/j.physbeh.2013.01.011

DO - 10.1016/j.physbeh.2013.01.011

M3 - Article

C2 - 23391573

AN - SCOPUS:84875067291

VL - 110-111

SP - 213

EP - 220

JO - Physiology and Behavior

JF - Physiology and Behavior

SN - 0031-9384

ER -